Literature DB >> 17699854

Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer.

Birgit Hotz1, Marco Arndt, Sonja Dullat, Sarah Bhargava, Heinz-J Buhr, Hubert G Hotz.   

Abstract

PURPOSE: Epithelial to mesenchymal transitions are vital for tumor growth and metastasis. Several inducers of epithelial to mesenchymal transition are transcription factors that repress E-cadherin expression, such as Snail, Slug, and Twist. In this study, we aimed to examine the expression of these transcription factors in pancreatic cancer. EXPERIMENTAL
DESIGN: The expression of Snail, Slug, and Twist was detected by immunohistochemistry in tissue samples from patients with pancreatic ductal adenocarcinoma. Five human pancreatic cancer cell lines (AsPC-1, Capan-1, HPAF-2, MiaPaCa-2, and Panc-1) were analyzed by reverse transcription-PCR, real-time PCR, and Western blotting. An orthotopic nude mouse model of pancreatic cancer was applied for in vivo experiments.
RESULTS: Seventy-eight percent of human pancreatic cancer tissues showed an expression of Snail, and 50% of the patients displayed positive expression of Slug. Twist showed no or only weak expression. Snail expression was higher in undifferentiated cancer cell lines (MiaPaCa-2 and Panc-1) than in more differentiated cell lines (Capan-1, HPAF-2, AsPC-1). Expression of Slug was detected in all cell lines with different intensities. Twist was not expressed. After exposure to hypoxia, the Twist gene was activated in all five pancreatic cancer cell lines.
CONCLUSIONS: The transcription factors Snail and Slug are expressed in pancreatic cancer but not in normal tissue, suggesting a role in the progression of human pancreatic tumors. Twist, activated by hypoxia, may play an important role in the invasive behavior of pancreatic tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699854     DOI: 10.1158/1078-0432.CCR-06-2926

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  188 in total

Review 1.  Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Roland M Schmid; Dieter Saur
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 2.  Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

Authors:  Daisuke Kyuno; Hiroshi Yamaguchi; Tatsuya Ito; Tsuyoshi Kono; Yasutoshi Kimura; Masafumi Imamura; Takumi Konno; Koichi Hirata; Norimasa Sawada; Takashi Kojima
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

4.  The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue.

Authors:  Han-Hua Dong; Shuai Xiang; Xiao-Ping Chen; Hui-Fang Liang; Wei Zhang; Kai Jing; Wei Zhang; Wan-Guang Zhang; Lin Chen
Journal:  Stem Cells Dev       Date:  2009-11       Impact factor: 3.272

5.  Functional analysis of LOXL2 in pancreatic carcinoma.

Authors:  Felix Rückert; Peer Joensson; Hans-Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2009-12-09       Impact factor: 2.571

Review 6.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

7.  Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications.

Authors:  Georg Lurje; Marc Schiesser; Andreas Claudius; Paul Magnus Schneider
Journal:  J Oncol       Date:  2009-11-05       Impact factor: 4.375

8.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

9.  BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.

Authors:  Vaibhav Sahai; Krishan Kumar; Lawrence M Knab; Christina R Chow; Sania S Raza; David J Bentrem; Kazumi Ebine; Hidayatullah G Munshi
Journal:  Mol Cancer Ther       Date:  2014-05-07       Impact factor: 6.261

10.  Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.

Authors:  Michael Herfs; Pascale Hubert; Natalia Kholod; Jean Hubert Caberg; Christine Gilles; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.